Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 90

1.

Adverse effects of salmeterol in asthma: a neuronal perspective.

Lommatzsch M, Lindner Y, Edner A, Bratke K, Kuepper M, Virchow JC.

Thorax. 2009 Sep;64(9):763-9. doi: 10.1136/thx.2008.110916. Epub 2009 Feb 22.

PMID:
19237390
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Effect of long-term salmeterol therapy compared with as-needed albuterol use on airway hyperresponsiveness.

Rosenthal RR, Busse WW, Kemp JP, Baker JW, Kalberg C, Emmett A, Rickard KA.

Chest. 1999 Sep;116(3):595-602.

PMID:
10492259
[PubMed - indexed for MEDLINE]
3.

Long-term effects of a long-acting beta 2-adrenoceptor agonist, salmeterol, on airway hyperresponsiveness in patients with mild asthma.

Cheung D, Timmers MC, Zwinderman AH, Bel EH, Dijkman JH, Sterk PJ.

N Engl J Med. 1992 Oct 22;327(17):1198-203.

PMID:
1357550
[PubMed - indexed for MEDLINE]
Free Article
4.

Salmeterol/fluticasone propionate (50/500 microg) in combination in a Diskus inhaler (Seretide) is effective and safe in the treatment of steroid-dependent asthma.

Aubier M, Pieters WR, Schlösser NJ, Steinmetz KO.

Respir Med. 1999 Dec;93(12):876-84.

PMID:
10653049
[PubMed - indexed for MEDLINE]
5.

Beta2-receptor polymorphisms in patients receiving salmeterol with or without fluticasone propionate.

Bleecker ER, Nelson HS, Kraft M, Corren J, Meyers DA, Yancey SW, Anderson WH, Emmett AH, Ortega HG.

Am J Respir Crit Care Med. 2010 Apr 1;181(7):676-87. doi: 10.1164/200809-1511OC. Epub 2009 Nov 12.

PMID:
19910613
[PubMed - indexed for MEDLINE]
6.

Salmeterol response is not affected by beta2-adrenergic receptor genotype in subjects with persistent asthma.

Bleecker ER, Yancey SW, Baitinger LA, Edwards LD, Klotsman M, Anderson WH, Dorinsky PM.

J Allergy Clin Immunol. 2006 Oct;118(4):809-16. Epub 2006 Aug 28.

PMID:
17030231
[PubMed - indexed for MEDLINE]
7.

[Efficacy and safety of salmeterol (50 microgram) and fluticasone (250 microgram) in a single inhaler device (diskus) in patients with mild to moderate asthma].

Beeh KM, Beier J, Kornmann O, Wiewrodt R, Buhl R; SAS 40011-Studiengruppe.

Pneumologie. 2002 Feb;56(2):91-7. German.

PMID:
11842346
[PubMed - indexed for MEDLINE]
8.

Fluticasone and ibuprofen do not add to the effect of salmeterol on organic dust-induced airway inflammation and bronchial hyper-responsiveness.

Strandberg K, Ek A, Palmberg L, Larsson K.

J Intern Med. 2008 Jul;264(1):83-94. doi: 10.1111/j.1365-2796.2008.01928.x. Epub 2008 Feb 21.

PMID:
18298484
[PubMed - indexed for MEDLINE]
9.
10.
11.

Initial treatment of symptomatic mild to moderate bronchial asthma with the salmeterol/fluticasone propionate (50/250 microg) combination product (SAS 40023).

Baumgarten C, Geldszus R, Behre U, Peslis N, Trautmann M; Viani-Initial Study Group.

Eur J Med Res. 2002 Jan 29;7(1):1-7.

PMID:
11827834
[PubMed - indexed for MEDLINE]
12.

Airway subsensitivity with long-acting beta 2-agonists. Is there cause for concern?

Lipworth BJ.

Drug Saf. 1997 May;16(5):295-308. Review.

PMID:
9187530
[PubMed - indexed for MEDLINE]
13.

Effects of low dose fluticasone/salmeterol combination on surrogate inflammatory markers in moderate persistent asthma.

Currie GP, Syme-Grant NJ, McFarlane LC, Carey FA, Lipworth BJ.

Allergy. 2003 Jul;58(7):602-7.

PMID:
12823118
[PubMed - indexed for MEDLINE]
14.

[Combination treatment with inhaled corticosteroid/long-acting beta 2-adrenergic bronchodilator in the treatment of asthma].

Kimura T, Adachi M.

Nihon Rinsho. 2001 Oct;59(10):1992-9. Review. Japanese.

PMID:
11676144
[PubMed - indexed for MEDLINE]
15.

Diurnal change of bronchial caliber and airway responsiveness in asthmatics during long-term treatment with long-acting beta 2-agonist salmeterol.

Dottorini ML, Tantucci C, Peccini F, Grassi V, Sorbini CA.

Int J Clin Pharmacol Ther. 1996 Oct;34(10):438-43.

PMID:
8897082
[PubMed - indexed for MEDLINE]
16.

Additive effects of salmeterol and fluticasone or theophylline in COPD.

Cazzola M, Di Lorenzo G, Di Perna F, Calderaro F, Testi R, Centanni S.

Chest. 2000 Dec;118(6):1576-81.

PMID:
11115442
[PubMed - indexed for MEDLINE]
17.

Asthma control during long-term treatment with regular inhaled salbutamol and salmeterol.

Taylor DR, Town GI, Herbison GP, Boothman-Burrell D, Flannery EM, Hancox B, Harré E, Laubscher K, Linscott V, Ramsay CM, Richards G.

Thorax. 1998 Sep;53(9):744-52. Erratum in: Thorax 1999 Feb;54(2):188.

PMID:
10319056
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Salmeterol: an inhaled beta 2-agonist with prolonged duration of action.

Lötvall J, Svedmyr N.

Lung. 1993;171(5):249-64. Review.

PMID:
8105155
[PubMed - indexed for MEDLINE]
19.

Control of mild to moderate asthma over 1-year with the combination of salmeterol and fluticasone propionate.

Lundbäck B, Rönmark E, Lindberg A, Jonsson AC, Larsson LG, Pétavy F, James M.

Respir Med. 2006 Jan;100(1):2-10. Epub 2005 Oct 21.

PMID:
16243498
[PubMed - indexed for MEDLINE]
Free Article
20.

Addition of salmeterol versus doubling the dose of fluticasone propionate in patients with mild to moderate asthma.

van Noord JA, Schreurs AJ, Mol SJ, Mulder PG.

Thorax. 1999 Mar;54(3):207-12.

PMID:
10325895
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk